Is Invitro International halal to invest in?

According to Musaffa's Shariah screening methodology, Invitro International (IVRO) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Invitro International a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Invitro International using these criteria to determine its compliance status.

Can Muslims buy shares of Invitro International?

Muslim investors may consider investing in Invitro International if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Invitro International classified as NOT COVERED?

Musaffa determines the Shariah status of Invitro International by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Invitro International updated?

The Shariah compliance status of Invitro International may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Invitro International become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Invitro International?

You can check the latest Shariah compliance status of Invitro International on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Invitro International. Stock Analysis IVRO

United States N/A Nano Cap

InVitro International engages in development and commercialization globally of test kits and laboratory services. The company is headquartered in Placentia, California. The Company’s testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its technologies are commercialized through test kits and laboratory services globally. The company operates in various industry segments providing in-vitro (non-animal) consumer, product and environmental safety test methods to customers in the cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation industries. Its Irritection Assay System is a vitro test method which uses changes of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures and product formulations. Its Irritection Assay System consists of an ocular test, Ocular Irritection and dermal test, Dermal Irritection. Corrositex is a non-animal test that determines skin corrosivity.

Key Statistics of Invitro International (IVRO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.07$0.08

Today's Open

$0.08

Volume

37.51K

P/E Ratio (TTM)

294.10

52 Week Range

$0.03$0.16

Market Cap

1.97M

Avg. Volume

119.11K

Dividend Yield

Financial Metrics & Statements of Invitro International (IVRO)

FAQ's for Invitro International (IVRO)

According to Musaffa’s Shariah screening methodology, Invitro International (IVRO) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.